Where Investors Back Tomorrow’s Technology Today
-
0
+
Investors
-
0
Unicorns
-
0
Year track record
POWERED BY CRIISPTM
Discover our AI-powered platform connecting VCs, High-Net-Worth Investors and Family Offices with Startup, Scaleup and Fund Opportunities
Personalised deal flow, streamlined information access and curated opportunities

Paycepaid

Recce Pharmaceuticals Ltd (ASX: RCE, FSE:R9Q)

neurocare group AG

Chimeric Therapeutics Ltd (ASX:CHM)

Auticon

Pacific Channel

Sales Director Central

weConnect
Access Exclusive Private Opportunities
Get access to leading emerging growth companies, private opportunities, alternative funds, venture investment education and exclusive investor events
- Free Account Set up
- No transaction fees
- Direct Access to CEOs

Paycepaid

Recce Pharmaceuticals Ltd (ASX: RCE, FSE:R9Q)

neurocare group AG

Chimeric Therapeutics Ltd (ASX:CHM)

Auticon

Pacific Channel

Sales Director Central

weConnect
A Personalised Pipeline of Opportunities
Let our AI/ML provide you with personalised, exclusive and consistent deal flow

Recce Pharmaceuticals Ltd (ASX: RCE, FSE:R9Q)

Chimeric Therapeutics Ltd (ASX:CHM)

Radiopharm Theranostics (ASX:RAD)

neurocare group AG

Paycepaid

Auticon

Pacific Channel

Sales Director Central

weConnect

Leonie Hill Ai
- Overview
- Market Opportunity
- Competitive Advantage
- Highlights and Milestones
- Investment Offering
Streamlined Investor Experience
Access the information you want and need, in a structured, clear format.
Trusted by hundreds of companies worldwide
Our international clientele includes leading emerging growth companies, funds, governments, universities, incubators, accelerators and advisory firms.
As seen in







Backed By Leading Investment Groups and Family Offices




Backed By Leading Investment Groups and Family Offices



